FibroGen (FGEN) P/E (2014 - 2026)
FibroGen (FGEN) P/E from Dec 31, 2014 to Jan 7, 2026. The TTM FibroGen (FGEN) P/E is 0.21. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of FibroGen (FGEN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 0.21 | +10.59% |
| 2025 | 0.19 | -117.44% |
| 2024 | -1.11 | +280.15% |
| 2023 | -0.29 | -92.95% |
| 2022 | -4.14 | -8.07% |
| 2021 | -4.50 | -74.45% |
| 2020 | -17.62 | -63.94% |
| 2019 | -48.86 | +8.83% |
| 2018 | -44.89 | +61.12% |
| 2017 | -27.86 | +65.36% |
| 2016 | -16.85 | -22.44% |
| 2015 | -21.73 | -31.95% |
| 2014 | -31.93 | N/A |
Comparison FibroGen (FGEN) P/E with competitors
FibroGen (FGEN) P/E is 0.21.